Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-064534
Filing Date
2021-05-11
Accepted
2021-05-11 16:13:48
Documents
63
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2111776d1_10q.htm 10-Q 456910
2 EXHIBIT 31.1 tm2111776d1_ex31-1.htm EX-31.1 11766
3 EXHIBIT 31.2 tm2111776d1_ex31-2.htm EX-31.2 11371
4 EXHIBIT 32.1 tm2111776d1_ex32-1.htm EX-32.1 4896
5 EXHIBIT 32.2 tm2111776d1_ex32-2.htm EX-32.2 4962
  Complete submission text file 0001104659-21-064534.txt   4935441

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT tmbr-20210331.xml EX-101.INS 1214443
7 XBRL TAXONOMY EXTENSION SCHEMA tmbr-20210331.xsd EX-101.SCH 56035
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tmbr-20210331_cal.xml EX-101.CAL 52454
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmbr-20210331_def.xml EX-101.DEF 214150
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmbr-20210331_lab.xml EX-101.LAB 416908
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmbr-20210331_pre.xml EX-101.PRE 339207
Mailing Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920
Business Address 110 ALLEN ROAD, SUITE 401 BASKING RIDGE NJ 07920 914-205-3481
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

EIN.: 593843182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37411 | Film No.: 21911454
SIC: 2834 Pharmaceutical Preparations